Automated Serum Bactericidal Assay with Sealed Fluorescent Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Traditional serum bactericidal assays for evaluating vaccine efficacy are time-consuming, labor-intensive, and not amenable to high-throughput analysis, leading to challenges in standardization and data accuracy, especially when assessing bacterial vaccine candidates.
Innovation Solution
An automated high-throughput serum bactericidal assay using a sealed, non-gel fluid with a metabolic indicator like resazurin (ALAMARBLUE™) for repeated measurements over time, allowing for accurate fluorescence or colorimetric signal measurement without agar and evaporation, and reducing interoperator variability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional SBA assay methods are used, then measurement accuracy can be maintained, but productivity is low and time consumption is high
Solution Approach 1:
The patent replaces the traditional mechanical plating and colony counting method with an automated fluorescence detection system. The SBA assay now uses automated liquid handling to dispense reagents and an automated plate reader to measure fluorescence signals from metabolic indicators, eliminating manual plating operations and enabling high-throughput processing while maintaining measurement accuracy.
Solution Approach 2:
The patent introduces metabolic indicators (fluorescent or colorimetric compounds) as intermediaries to detect bacterial viability. Instead of directly counting colonies, the assay measures the metabolic activity of surviving bacteria through these indicators, which convert bacterial metabolic states into detectable optical signals that can be rapidly quantified by automated systems.
2Measurement precision
If traditional SBA assay methods are used, then measurement accuracy can be maintained, but labor requirements are high
Solution Approach 1:
The patent implements automated liquid handling systems that automatically dispense sera, bacterial suspensions, and metabolic indicators into microtiter plates according to pre-programmed protocols. The system performs serial dilutions, incubation, and signal measurement without manual intervention, reducing labor requirements while maintaining assay precision through consistent, programmable operations.
Solution Approach 2:
The patent replaces manual plating techniques with automated fluorescence-based detection in microtiter plates. The automated plate reader systematically measures fluorescence signals from all wells without human intervention, eliminating the labor-intensive process of manual colony counting while preserving measurement accuracy through standardized optical detection.
3Productivity
If automated high-throughput methods are used, then productivity is improved, but device complexity increases
Solution Approach 1:
The patent employs automated liquid handling platforms and plate readers that are designed to perform multiple functions: dispensing various reagents, creating serial dilutions, incubating plates, and measuring optical signals. These multi-functional devices can handle different assay formats and reagent types, reducing the need for specialized equipment while achieving high throughput.
Solution Approach 2:
The patent adapts the traditional SBA assay by changing key parameters: using metabolic indicators instead of colony counting, performing assays in microtiter plates instead of Petri dishes, and using automated detection instead of manual counting. These parameter changes enable the assay to be performed in high-throughput formats using standardized automated equipment without requiring entirely new device designs.
4Reliability
If traditional SBA assay methods are used, then data reliability can be maintained, but standardization across laboratories is difficult
Solution Approach 1:
The patent standardizes the assay by changing from variable manual operations to fixed automated protocols. The automated liquid handling systems dispense precise volumes with consistent accuracy, and the plate readers measure signals under standardized optical conditions. These parameter standardizations ensure that assays performed in different laboratories yield comparable results, improving inter-laboratory reliability.
Solution Approach 2:
The patent replaces manual plating and counting operations with automated fluorescence detection, which is inherently more amenable to standardization. The automated systems use programmable protocols that can be replicated across laboratories, and the optical detection method provides objective, quantifiable data that is less susceptible to operator variability than manual colony counting.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables rapid, reproducible, and accurate assessment of bactericidal activity, improving data accuracy and throughput, and facilitating the evaluation of vaccine efficacy across different laboratories.
Implementation Method 1
Viable cells reduce ALAMARBLUE changing the color from blue to pink for colorimetric measurement and are emitting a fluorescence signal after excitation
Implementation Method 2
Viable cells reduce ALAMARBLUE changing the color from blue to pink
Data Source
AI summary
The disclosure provides methods and kits for performing automated high-throughput assays to measure bactericidal activity in samples, such as plasma or sera from vaccinated subjects to evaluate the efficacy of vaccines against bacterial pathogens. The method combines obligatory linear-range data analysis, plate sealing and liquid volume handling for all assay steps to provide an automated, high-throughput measurement of bactericidal activity with favorable inter-assay and inter-operator variability.